13
Working Together: New hepa22s C therapies and ensuring op2mal access for indigenous communi2es Paul Su=on Manager, Government Affairs

Working Together: New hepa2s C therapies and …...Update on access to new hepa2s C therapies on NIHB and other public drug plans 2. Lessons learned from AbbVie’s engagement with

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Working Together: New hepa2s C therapies and …...Update on access to new hepa2s C therapies on NIHB and other public drug plans 2. Lessons learned from AbbVie’s engagement with

WorkingTogether:Newhepa22sCtherapiesandensuringop2malaccessforindigenouscommuni2esPaulSu=onManager,GovernmentAffairs

Page 2: Working Together: New hepa2s C therapies and …...Update on access to new hepa2s C therapies on NIHB and other public drug plans 2. Lessons learned from AbbVie’s engagement with

Agenda

2WorkingTogether–WisePrac2cesV|July2015|CompanyConfiden2al©2015

1.  Updateonaccesstonewhepa22sCtherapiesonNIHBandotherpublicdrugplans

2.  LessonslearnedfromAbbVie’sengagementwithFirstNa2ons,InuitandMé2sorganiza2onsandpeoplewithlivedexperience

3.  Ongoingpolicyneedsandupcomingadvocacyopportuni2esforIndigenousPeoplelivingwithand/oraffectedbyhepa22sC

4.  AbbVieCare:Doingourparttoempowersafe,accessibleandculturallycompetenthepa22sCcareforIndigenousPeople

5.  SharedVisionsandGoals:Workingtogethertoeliminatehepa22sC

Page 3: Working Together: New hepa2s C therapies and …...Update on access to new hepa2s C therapies on NIHB and other public drug plans 2. Lessons learned from AbbVie’s engagement with

Ournamewaslaunchedin2013butourstorybeginsin1888

125yearsofcare

Addressingcomplexandseriousdiseases

Makingaremarkableimpactonpeoples’lives

3WorkingTogether–WisePrac2cesV|July2015|CompanyConfiden2al©2015

Page 4: Working Together: New hepa2s C therapies and …...Update on access to new hepa2s C therapies on NIHB and other public drug plans 2. Lessons learned from AbbVie’s engagement with

Weworktounderstandwhatsurroundspeople

4

Understandingtheen2reexperience

Understandingdiseaseateverystage

Understandingthedevelopment,manufacture,anddeliveryofmedicinetoprovideconvenient,reliabletherapeu2cs

Understandingthehealthcaresystem

Supportprograms

People

Disease

Manufacture

Experience

System

Delivery

Support

WorkingTogether–WisePrac2cesV|July2015|CompanyConfiden2al©2015

Page 5: Working Together: New hepa2s C therapies and …...Update on access to new hepa2s C therapies on NIHB and other public drug plans 2. Lessons learned from AbbVie’s engagement with

New,interferon-sparingHCVregimens:Summary

5WorkingTogether–WisePrac2cesV|July2015|CompanyConfiden2al©2015

§  Alloralanddoesnotrequirepeg-interferon.

§  Treatmentdura2onisonly12weeksformajorityofpa2ents.

§  HighSVRRates(over90%,someaveraging97%)

§  Welltolerated(lowratesofdiscon2nua2onsduetoadverseevents).

Page 6: Working Together: New hepa2s C therapies and …...Update on access to new hepa2s C therapies on NIHB and other public drug plans 2. Lessons learned from AbbVie’s engagement with

Interferon-freehepa22sCtherapies:publicaccessupdate

Source:CommonDrugReview,availableonlineatwww.cadth.ca/cdr.

13WorkingTogether–WisePrac2cesV|July2015|CompanyConfiden2al©2015

CDECFINALRECOMMENDATIONIndica2on:ChronicHepa22sCVirusGenotype1Infec2oninAdultsListedforthetreatmentofadultswithgenotype1chronichepa22sCvirus(CHC)infec2on,includingthosewithcompensatedcirrhosis,ifthefollowingclinicalcriterionandcondi2onsaremet:Clinicalcriterion:Liverfibrosisstageof≥2.Condi2ons:Treatmentshouldbeini2atedbyphysicianswithexperienceinthemanagementofCHCpa2ents.

Whataresomechallengeswiththislimita1on?

Page 7: Working Together: New hepa2s C therapies and …...Update on access to new hepa2s C therapies on NIHB and other public drug plans 2. Lessons learned from AbbVie’s engagement with

Hepa22sC&IndigenousCommuni2es:ChallengesandLessonsLearned

7WorkingTogether–WisePrac2cesV|July2015|CompanyConfiden2al©2015

§  Largeburdenwithinmanyindigenouscommuni2es

§  Scaleofhepa22sCinfec2onsnotwellunderstood

§  Screeningiswidelyunavailable,andevenwhenitis,itmaynotbesafeoraccessible

§  Majorbarriersinhepa22sCcare,especiallyinremotecommuni2esoronreserve

§  F2andaboveliverdamagerestric2onmeansthatinsteadoftrea2ngpeople,peoplemustwaitun2lthey’reverysicktogetcured

Page 8: Working Together: New hepa2s C therapies and …...Update on access to new hepa2s C therapies on NIHB and other public drug plans 2. Lessons learned from AbbVie’s engagement with

AllNa2onsHopeHepa22sCWorkshop:LessonsLearned

8WorkingTogether–WisePrac2cesV|July2015|CompanyConfiden2al©2015

§  SRgmaanddiscriminaRon:Livingwithandmanaginghepa22sCisverydifferentfrompersontoperson

§  Accesstoscreeningandscreeningprogramsmustberootedinrespect

§  Trauma–bothsystemic,historical,andpersonal–isthekeydeterminantofhepa22sCvulnerability

§  ImprovedcommunicaRonbyorganiza2onsandindustryaroundimprovementsintherapies

§  HepaRRsCtreatmentandcareforindigenouspeoplemustbepartofahealingjourney,connec2ngindividualpeoplewithindigenousorganiza2onsandresourcessothattherapyisgroundedintradi2onalhealing–andtreatmentitselfbecomesanopportunityforotherdeterminantsofhealthtobeaddressed

Page 9: Working Together: New hepa2s C therapies and …...Update on access to new hepa2s C therapies on NIHB and other public drug plans 2. Lessons learned from AbbVie’s engagement with

OngoingPolicyIssuesandUnmetNeeds

§  PublicHealthAgencyofCanadacon2nueddelayinnewna2onalstrategyontes2ng,previouslyexpectedDecember2014

§  Understandingthatscreening,formanyindigenouscommuni2es,isanongoingprocessofbuildingtrustandcapacitywithincommuni2estoensuresupportsareavailableincaseofposi2vediagnosis§  AbbVieissuppor2ngpilotprogramsacrossthecountrysuppor2ngclinicianstoworkwithindigenousleadershiptoproviderespeclul,culturallycompetentscreeningprograms

WorkingTogether–WisePrac2cesV|July2015|CompanyConfiden2al©2015 9

Screening

Page 10: Working Together: New hepa2s C therapies and …...Update on access to new hepa2s C therapies on NIHB and other public drug plans 2. Lessons learned from AbbVie’s engagement with

OngoingPolicyIssuesandUnmetNeeds

§  2016FirstNa2onsandInuitHealthBranchHIV,Hepa22sCandSTBBIStrategy§  Crucialtoincludemeaningful,measurabletargets(i.e.

screening,linkagetocare,treatmentoffereddespiteliverfibrosisscore)

§  CAANandPauktuu2tHepa22sCStrategies§  EngagingIndigenousLeadership(i.e.AFN,ITK,Mé2sNa2on)

§  Na2onalAboriginalHepa22sCAwarenessMonthhasestablisheditselfasacrucialengagementopportunity

WorkingTogether–WisePrac2cesV|July2015|CompanyConfiden2al©2015 10

OpportuniRes

Page 11: Working Together: New hepa2s C therapies and …...Update on access to new hepa2s C therapies on NIHB and other public drug plans 2. Lessons learned from AbbVie’s engagement with

AbbVieCare:Op2mizingforIndigenousPeoplewithHepa22sC

WhatisAbbVieCare?Acomprehensiveprogramaimingtoensurepa2ents,physiciansandnursesaresupportedthroughoutthetreatmentprocess.Includes: DedicatedCareCoach(availablebyphone)

Reimbursement/coverageandfinancialsupport Pharmacycoordina2on/support(esp.relevantforNIHB) Adherencetools

HowareweopRmizingforIndigenousPeoplewithHepaRRsC?§  Learninguniqueneedsforpeoplewithlivedexperience§  Recogni2onthat1-on-1supportiskey§  Undertakingaflexibleapproachtohelpempowerclinicsandpeoplewithhepa22sConop2malwaystoconnectforsupport§  Moreconsulta2onsahead…

WorkingTogether–WisePrac2cesV|July2015|CompanyConfiden2al©2015 11

Page 12: Working Together: New hepa2s C therapies and …...Update on access to new hepa2s C therapies on NIHB and other public drug plans 2. Lessons learned from AbbVie’s engagement with

12WorkingTogether–WisePrac2cesV|July2015|CompanyConfiden2al©2015

HepaRRsCDiagnosis

&Treatment

StabilizedHousing

MentalHealthServices

TradiRonalMedicines

andHealing

FoodandIncomeSecurity

MentalHealth

PhysicalHealth

SpiritualHealth

EmoRonalHealth

Whatneedstobeinplacetobuildaholis2chealingjourney?

Page 13: Working Together: New hepa2s C therapies and …...Update on access to new hepa2s C therapies on NIHB and other public drug plans 2. Lessons learned from AbbVie’s engagement with

Presenta2onTitle|Datexx.xx.xx|CompanyConfiden2al©2013 13